Lupus patient organizations are working to launch the World Lupus Federation (WLF), a new coalition aiming to improve life for the more…
Ines Martins, PhD
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ines Martins, PhD
May is Lupus Awareness Month, and the Lupus Foundation of America has started a Know Lupus campaign to increase public understanding…
A California lawmaker, Sen. John Moorlach, has led a successful effort to designate May as California Lupus Awareness Month. The…
TxCell SA and Ospedale San Raffaele (OSR) announced the launch of a strategic research and development collaboration that will include efforts to treat  …
French company NEOVACS announced that its Investigational New Drug (IND) application for IFNα Kinoid in lupus, now in Phase 2b development,…
QuesGen Systems, a provider of research services to organizations and scientists working on brain health and treatments for…
Three organizations focused on helping patients with lupus are banding together once again to recognize an outstanding research project. The…
The American Autoimmune Related Diseases Association (AARDA) is celebrating its 25th anniversary this month with the inauguration of its…
The Lupus Foundation of America has announced two new staff appointments: Susan Manzi, M.D., MPH, the chief adviser of…
ImmuPharma PLC announced that Phase 3 clinical studies evaluating the safety and efficacy of Lupuzor — its lead compound to treat lupus –…